Vanguard Growth ETF Portfolio (TSE:VGRO - Get Free Report) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as C$39.56 and last traded at C$39.56, with a volume of 52390 shares trading hands. The stock had previously closed at C$39.40.
Vanguard Growth ETF Portfolio Stock Up 0.1%
The firm's fifty day moving average is C$38.66 and its 200-day moving average is C$37.80.
Vanguard Growth ETF Portfolio Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 9th. Shareholders of record on Wednesday, July 9th were issued a dividend of $0.2123 per share. This represents a $0.85 dividend on an annualized basis and a dividend yield of 2.14%. This is a boost from Vanguard Growth ETF Portfolio's previous quarterly dividend of $0.18. The ex-dividend date of this dividend was Wednesday, July 2nd.
Vanguard Growth ETF Portfolio Company Profile
(
Get Free Report)
Vanguard Growth ETF Portfolio (the ETF) seeks to provide long-term capital growth. Fund investing in equity and fixed income securities. The ETF may do so either directly or indirectly through investment in one or more exchange-traded funds managed by Vanguard Investments Canada Inc (the Manager) or an affiliate or certain other investment funds (Underlying Funds).
Recommended Stories
Before you consider Vanguard Growth ETF Portfolio, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vanguard Growth ETF Portfolio wasn't on the list.
While Vanguard Growth ETF Portfolio currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access